Mayo Clinic experts are using AI to better detect sleep apnea, especially in women. Learn more from Mayo Clinic.

Rochester, Minn.-based Mayo Clinic has developed an AI algorithm that can detect obstructive sleep apnea using electrocardiogram results.

Zepbound is the name of the first drug approved by the FDA for obstructive sleep apnea. According to the Mayo Clinic, obstructive sleep apnea is a common sleep-related breathing disorder that occurs ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea ...

GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, ...

TUESDAY, Oct. 21, 2025 (HealthDay News) — Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients ...

Weight loss pills and injections are often touted as miracle drugs. Research shows that they can help you lose weight, better help you manage type II diabetes, and even reduce your risk of heart ...

INDIANAPOLIS (WISH) — Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep — they stop breathing sometimes 20 to 50 to 100 times a night and ...

Mayo Clinic has opened its new $3.8 million, 10,000-square-foot Sleep Disorders Center on its Jacksonville, Fla., campus, according to a health system news report. Mayo Clinic’s Sleep Disorders Center ...